生物学的サンプル採取キット市場：製品タイプ、サンプルタイプ、用途、エンドユーザー別-2025-2030年世界予測

生物学的サンプル採取キット市場は、2023年に86億米ドルと評価され、2024年には93億1,000万米ドルに達すると予測され、CAGR 8.57％で成長し、2030年には152億9,000万米ドルになると予測されています。

生物学的サンプル採取キットは、血液、尿、唾液、組織などの生物学的サンプルを採取するためのツールであり、診断、医学研究、個人の健康モニタリングに不可欠です。これらのキットは、病気の診断、個別化医療の開発、遺伝子研究の実施など、ヘルスケアや研究分野で非常に必要とされています。最終用途の範囲は、病院、診断研究所、研究機関、在宅ヘルスケアに及ぶ。市場成長要因としては、感染症や慢性疾患の蔓延、個別化医療に対する需要の高まり、バイオテクノロジーの進歩などが挙げられます。また、遠隔医療が拡大する中、遠隔患者モニタリングの採用が在宅採取キットの需要を高めています。非侵襲的な出生前検査やeコマース・プラットフォームを通じたアクセスの拡大など、これらのキットの用途を拡大することで、増大する消費者需要に対応する主な機会が存在します。企業はまた、ゲノミクスやバイオバンク・プロジェクトに対する政府や機関の資金提供の増加も活用できます。しかし、厳しい規制ガイドライン、潜在的なサンプル汚染リスク、収集と輸送のロジスティクスの複雑さなどが市場成長の課題となっています。さらに、新興国市場における市場開拓は、ヘルスケアのインフラが限られていることや、消費者の意識が低いことなどの理由で、ハードルに直面しています。イノベーションの機会は、より使いやすいキットの開発、サンプルの安定性の向上、ヘルスケアプロバイダーとのシームレスなデータ統合のためのデジタルソリューションの統合にあります。サンプル処理の自動化やコールドチェーン・ロジスティクスの改善も成長の可能性をもたらします。市場はダイナミックで、主要企業が研究開発や戦略的提携に投資する競合情勢となっています。事業成長を目指す企業は、継続的なイノベーション、戦略的パートナーシップ、デジタル化によるリーチの拡大に注力し、既存市場と新興市場の両方に参入する必要があります。

市場力学：急速に進化する生物学的サンプル採取キット市場の主要市場インサイトを公開

生物学的サンプル採取キット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症の急増と医学研究の継続的ニーズ
  • サンプルの収集、保管、輸送に関する厳しい規制の有無
  • 世界の診断センターの開発増加
• 市場抑制要因
  • 高品質の採取キットのメンテナンスの複雑さ
• 市場機会
  • 生物学的サンプル採取キットにおける継続的な技術改善
  • ポイントオブケアおよび在宅検査ソリューションへの新たな動向
• 市場の課題
  • キットの不適切な設計と結果の不正確さ

ポーターのファイブフォース：生物学的サンプル採取キット市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生物学的サンプル採取キット市場における外部からの影響の把握

外部マクロ環境要因は、生物学的サンプル採取キット市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生物学的サンプル採取キット市場における競合情勢の把握

生物学的サンプル採取キット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生物学的サンプル採取キット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生物学的サンプル採取キット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生物学的サンプル採取キット市場における成功への道筋を描く

生物学的サンプル採取キット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の増加と医学調査の継続的な必要性
    • サンプルの収集、保管、輸送に関する厳格な規制の有無
    • 世界中で診断センターの開発が増加
  • 抑制要因
    • 高品質の採取キットの維持管理の複雑さ
  • 機会
    • 生物学的サンプル採取キットの継続的な技術的改善
    • ポイントオブケアと在宅検査ソリューションへの新たなトレンド
  • 課題
    • キットの不適切な設計と結果の不正確さ
• 市場セグメンテーション分析
  • 製品タイプ：血液サンプルを効率的かつ安全に採取するための採血キットの使用が増加
  • エンドユーザー：診断センター全体でさまざまな種類の生物学的サンプルを収集するための血液採取キットの高い可能性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 生物学的サンプル採取キット市場：製品タイプ別

• 採血キット
• 綿棒
• ウイルス輸送メディア

第7章 生物学的サンプル採取キット市場サンプルタイプ別

• 血
• 唾液
• スツール
• 組織
• 尿

第8章 生物学的サンプル採取キット市場：用途別

• 診断
• 治療

第9章 生物学的サンプル採取キット市場：エンドユーザー別

• 血液銀行
• 診断センター
• 病院

第10章 南北アメリカの生物学的サンプル採取キット市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の生物学的サンプル採取キット市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの生物学的サンプル採取キット市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • タカラバイオの市場初の大規模シングルセルNGSプロファイリング技術がバイオマーカー発見に革命を起こす
  • BD、革新的技術を秘めた指先採血デバイスでFDA 510（k）認可を取得
  • Cue Healthの新しい在宅診断テストスイートとCue Careの拡張により、健康を自分で管理できるようになります
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Avantor, Inc.
• B. Braun SE
• Becton, Dickinson, and Company
• Bio-Rad Laboratories, Inc.
• Biosigma S.p.A.
• Cardinal Health, Inc.
• Eurofins Scientific SE
• Exelint International, Co.
• F. Hoffmann-La Roche Ltd.
• F.L. Medical S.r.l.
• Globe Scientific Inc.
• Greiner AG
• Haemonetics Corporation
• ICU Medical, Inc.
• Medtronic PLC
• Merck KGaA
• Nipro Medical Corporation
• Qiagen N.V.
• Retractable Technologies, Inc.
• Siemens Healthineers AG
• Terumo Corporation
• Thermo Fisher Scientific Inc.
• Zymo Research Corporation

LIST OF FIGURES

• FIGURE 1. BIOLOGICAL SAMPLE COLLECTION KITS MARKET RESEARCH PROCESS
• FIGURE 2. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BIOLOGICAL SAMPLE COLLECTION KITS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOLOGICAL SAMPLE COLLECTION KITS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STOOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CHINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. INDIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ITALY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. POLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. QATAR BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BIOLOGICAL SAMPLE COLLECTION KITS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. BIOLOGICAL SAMPLE COLLECTION KITS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. BIOLOGICAL SAMPLE COLLECTION KITS MARKET, FPNV POSITIONING MATRIX, 2023

The Biological Sample Collection Kits Market was valued at USD 8.60 billion in 2023, expected to reach USD 9.31 billion in 2024, and is projected to grow at a CAGR of 8.57%, to USD 15.29 billion by 2030.

Biological sample collection kits are tools used to collect biological samples such as blood, urine, saliva, or tissue, which are essential for diagnosis, medical research, and personal health monitoring. These kits are highly necessary in the healthcare and research sectors for diagnosing diseases, developing personalized medicine, and conducting genetic research, among other applications. The end-use scope spans hospitals, diagnostic laboratories, research institutes, and home healthcare. Market growth factors include the increasing prevalence of infectious diseases and chronic illnesses, rising demand for personalized medicine, and advancements in biotechnology. Additionally, the adoption of remote patient monitoring amid telehealth expansions has increased the demand for at-home collection kits. Key opportunities exist in expanding these kits' applications, such as non-invasive prenatal testing or expanding access through e-commerce platforms to meet the growing consumer demand. Companies can also capitalize on increasing governmental and institutional funding for genomics and biobanking projects. However, market growth is challenged by stringent regulatory guidelines, potential sample contamination risks, and the logistical complexity of collection and transport. Additionally, market penetration in developing regions faces hurdles due to limited healthcare infrastructure and lesser consumer awareness. Innovation opportunities lie in developing more user-friendly kits, enhancing sample stability, and integrating digital solutions for seamless data integration with healthcare providers. Automation in sample processing and improved cold chain logistics can also present growth avenues. The market is dynamic, with a competitive landscape featuring key players investing in R&D and strategic collaborations. Companies aiming for business growth should focus on continuous innovation, strategic partnerships, and expanding their reach through digitalization to tap into both established and emerging markets, ensuring adaptive strategies to leverage the growing emphasis on personalized and predictive healthcare solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Sample Collection Kits Market

The Biological Sample Collection Kits Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising emergence of infectious diseases and the ongoing need for medical research
  • Availability of stringent regulations regarding sample collection, storage, and transportation
  • Increasing development of diagnostic centers worldwide
• Market Restraints
  • Complexity in the maintenance of high-quality collection kits
• Market Opportunities
  • Ongoing technological improvements in biological sample collection kits
  • Emerging trend towards point-of-care and at-home testing solutions
• Market Challenges
  • Improper design of kits and inaccuracy of results

Porter's Five Forces: A Strategic Tool for Navigating the Biological Sample Collection Kits Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Sample Collection Kits Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Sample Collection Kits Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Sample Collection Kits Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Sample Collection Kits Market

A detailed market share analysis in the Biological Sample Collection Kits Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Sample Collection Kits Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Sample Collection Kits Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Sample Collection Kits Market

A strategic analysis of the Biological Sample Collection Kits Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Collection Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Eurofins Scientific SE, Exelint International, Co., F. Hoffmann-La Roche Ltd., F.L. Medical S.r.l., Globe Scientific Inc., Greiner AG, Haemonetics Corporation, ICU Medical, Inc., Medtronic PLC, Merck KGaA, Nipro Medical Corporation, Qiagen N.V., Retractable Technologies, Inc., Siemens Healthineers AG, Terumo Corporation, Thermo Fisher Scientific Inc., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biological Sample Collection Kits Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Blood Collection Kits, Swabs, and Viral Transport Media.
• Based on Sample Type, market is studied across Blood, Saliva, Stool, Tissue, and Urine.
• Based on Application, market is studied across Diagnostics and Treatment.
• Based on End-User, market is studied across Blood Banks, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising emergence of infectious diseases and the ongoing need for medical research
    • 5.1.1.2. Availability of stringent regulations regarding sample collection, storage, and transportation
    • 5.1.1.3. Increasing development of diagnostic centers worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. Complexity in the maintenance of high-quality collection kits
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological improvements in biological sample collection kits
    • 5.1.3.2. Emerging trend towards point-of-care and at-home testing solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Improper design of kits and inaccuracy of results
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Growing usage of blood collection kits for the efficient and safe collection of blood samples
  • 5.2.2. End-User: High potential of blood collection kits across diagnostic centers for collecting various types of biological samples
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biological Sample Collection Kits Market, by Product Type

• 6.1. Introduction
• 6.2. Blood Collection Kits
• 6.3. Swabs
• 6.4. Viral Transport Media

7. Biological Sample Collection Kits Market, by Sample Type

• 7.1. Introduction
• 7.2. Blood
• 7.3. Saliva
• 7.4. Stool
• 7.5. Tissue
• 7.6. Urine

8. Biological Sample Collection Kits Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Treatment

9. Biological Sample Collection Kits Market, by End-User

• 9.1. Introduction
• 9.2. Blood Banks
• 9.3. Diagnostic Centers
• 9.4. Hospitals

10. Americas Biological Sample Collection Kits Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biological Sample Collection Kits Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Collection Kits Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Takara Bio's First-to-market Large-Scale Single-cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery
  • 13.3.2. BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
  • 13.3.3. Cue Health's New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Avantor, Inc.
• 4. B. Braun SE
• 5. Becton, Dickinson, and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. Biosigma S.p.A.
• 8. Cardinal Health, Inc.
• 9. Eurofins Scientific SE
• 10. Exelint International, Co.
• 11. F. Hoffmann-La Roche Ltd.
• 12. F.L. Medical S.r.l.
• 13. Globe Scientific Inc.
• 14. Greiner AG
• 15. Haemonetics Corporation
• 16. ICU Medical, Inc.
• 17. Medtronic PLC
• 18. Merck KGaA
• 19. Nipro Medical Corporation
• 20. Qiagen N.V.
• 21. Retractable Technologies, Inc.
• 22. Siemens Healthineers AG
• 23. Terumo Corporation
• 24. Thermo Fisher Scientific Inc.
• 25. Zymo Research Corporation